Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits ; volume:6 ; number:1 ; day:28 ; month:7 ; year:2020 ; pages:1-9 ; date:12.2020
International Journal of Retina and Vitreous ; 6, Heft 1 (28.7.2020), 1-9, 12.2020
- Urheber
-
Baiza-Durán, Leopoldo
Sánchez-Ríos, Alejandra
González-Barón, Joel
Olvera-Montaño, Oscar
Correa-Gallegos, Elba
Navarro-Sánchez, Andrea
Muñoz-Villegas, Patricia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-020-00235-y
- URN
-
urn:nbn:de:101:1-2020092420275707261998
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baiza-Durán, Leopoldo
- Sánchez-Ríos, Alejandra
- González-Barón, Joel
- Olvera-Montaño, Oscar
- Correa-Gallegos, Elba
- Navarro-Sánchez, Andrea
- Muñoz-Villegas, Patricia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study